Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma (HO95)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
European Myeloma Network
GIMEMA (Italian Group for Adult Hematologic Diseases)
DSMM (Deutsche Studiengruppe Multiples Myelom)
NMSG (Nordic Myeloma Study Group)
Central European Myeloma Study Group
Information provided by (Responsible Party):
Stichting Hemato-Oncologie voor Volwassenen Nederland
ClinicalTrials.gov Identifier:
NCT01208766
First received: September 23, 2010
Last updated: March 19, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2021
  Estimated Primary Completion Date: April 2021 (Final data collection date for primary outcome measure)